Insulin prices doubled between 2012 and 2016

The historical excuse for pharma monopolists who conspired to rig prices on insulin was that hardly anyone paid full price — everyone got their life-saving, non-optional medicine through health plans that negotiated a knock-down price. That was the line between 2012 and 2016, as median per-patient insulin costs rose 99%, to $5,705/year. But now prices … Continue reading Insulin prices doubled between 2012 and 2016